ReviewNature reviews. Microbiology2007
Pathogen profiling for disease management and surveillance.
Review in Nature reviews. Microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Pathogen to read: a rapid, automated workflow for public health-ready microbial sequencing.BMC genomics · 2026Article
- Performance of predictive AI-based clinical decision support systems across clinical domains: A systematic review and meta-analysis.PLOS digital health · 2026Article
- Gut microbes on the risk of advanced adenomas.BMC microbiology · 2024Article
- Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge.Cell death & disease · 2022Article
- Microbial degradation and community structure analysis of hydroxyl-terminated polybutadiene (HTPB).AMB Express · 2021Article
- Using MALDI-TOF spectra in epidemiological surveillance for the detection of bacterial subgroups with a possible epidemic potential.BMC infectious diseases · 2021Article
- Droplet-Based Single-Cell Measurements of 16S rRNA Enable Integrated Bacteria Identification and Pheno-Molecular Antimicrobial Susceptibility Testing from Clinical Samples in 30 min.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021Article
- Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.Nature medicine · 2020Article
- Toward Nanopore Electrospray Mass Spectrometry: Nanopore Effects in the Analysis of Bacteria.ACS central science · 2020Article
- Community perspectives on the benefits and risks of technologically enhanced communicable disease surveillance systems: a report on four community juries.BMC medical ethics · 2020Article
- Insights Into Subspecies Discrimination Potentiality From Bacteria MALDI-TOF Mass Spectra by Using Data Mining and Diversity Studies.Frontiers in microbiology · 2020Article
- Phylogenomic Pipeline Validation for Foodborne Pathogen Disease Surveillance.Journal of clinical microbiology · 2019Review
- Advances in Clinical Sample Preparation for Identification and Characterization of Bacterial Pathogens Using Metagenomics.Frontiers in public health · 2018Review
- Sharing and Reuse of Sensitive Data and Samples: Supporting Researchers in Identifying Ethical and Legal Requirements.Biopreservation and biobanking · 2015Article
- The role of gut microbiota in the gut-brain axis: current challenges and perspectives.Protein & cell · 2013Review
- Translational web robots for pathogen genome analysis.Microbial informatics and experimentation · 2011Article
- Microbial metabolomics.Current genomics · 2011Article
- Defining reference sequences for Nocardia species by similarity and clustering analyses of 16S rRNA gene sequence data.PloS one · 2011Article
- Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.PloS one · 2010Article
- A PubMed-wide associational study of infectious diseases.PloS one · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The usefulness of rapid pathogen genotyping is widely recognized, but its effective interpretation and application requires integration into clinical and public health decision-making. How can pathogen genotyping data best be translated to inform disease management and surveillance? Pathogen profiling integrates microbial genomics data into communicable disease control by consolidating phenotypic identity-based methods with DNA microarrays, proteomics, metabolomics and sequence-based typing. Sharing data on pathogen profiles should facilitate our understanding of transmission patterns and the dynamics of epidemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.